Alexandria Real Estate Equities enters third quarter earnings with lower stock valuation

Alexandria Real Estate Equities is heading into its third quarter 2026 earnings release after the market closes, Simply Wall Street reported. Investors are observing how life science leasing, interest costs, and dividend sustainability intersect for the real estate investment trust. [1]

According to Simply Wall Street, momentum for the company has weakened over the past year. The share price reached 41.62 US dollars following a 30-day share price return that dropped 21.91 percent. [1]

Alexandria Real Estate Equities is a Pasadena, California-based real estate investment trust that invests in office buildings and laboratories leased to tenants in the life science and technology sectors. Founded in 1994 with 19 million US dollars in capital, the firm pioneered the life science real estate niche. Its operating portfolio spans roughly 39.1 million rentable square feet, alongside 4.2 million rentable square feet under construction for approximately 700 tenants across major innovation clusters. [9][11]

The company owns several major technology and biotechnology campuses. These holdings include the 740,972 square foot Alexandria Center for Life Science in Manhattan, as well as the 2,365,487 square foot Alexandria Center at Kendall Square and the 1,181,635 square foot Technology Square in the Boston area. [9]